• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性骨髓瘤 MRI 早期治疗反应评估:全身弥散加权和腰椎 MRI 的对比研究。

Assessment of early treatment response on MRI in multiple myeloma: Comparative study of whole-body diffusion-weighted and lumbar spinal MRI.

机构信息

Department of Diagnostic Radiology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.

Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.

出版信息

PLoS One. 2020 Feb 27;15(2):e0229607. doi: 10.1371/journal.pone.0229607. eCollection 2020.

DOI:10.1371/journal.pone.0229607
PMID:32106239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7046272/
Abstract

OBJECTIVES

To compare remission status at completion of chemotherapy for multiple myeloma (MM) with changes in total diffusion volume (tDV) calculated from whole-body diffusion-weighted imaging (WB-DWI) and fat fraction (FF) of lumbar bone marrow (BM) by modified Dixon Quant (mDixon Quant) soon after induction of chemotherapy, and to assess the predictive value of MRI.

METHODS

Fifty patients (mean age, 66.9 ± 10.5 years) with symptomatic myeloma were examined before and after two cycles of chemotherapy. From WB-DWI data, tDV was obtained with the threshold for positive BM involvement. Mean FF was calculated from lumbar BM using the mDixon Quant sequence. At the completion of chemotherapy, patients were categorized into a CR/very good PR (VGPR) group (n = 15; mean age, 67.6 ± 10.3 years) and a PR, SD or PD group (n = 35; mean age, 69.1 ± 8.6 years). ROC curves were plotted to assess performance in predicting achievement of CR/VGPR.

RESULTS

At second examination, serum M protein, β2-microglobulin, and tDV were significantly decreased and hemoglobin, mean ADC, and FF were significantly increased in the CR/VGPR group and serum M protein was significantly increased in the PR/SD/PD group. The general linear model demonstrated that percentage changes in FF and M protein contributed significantly to achieving CR/VGPR (P = 0.02, P = 0.04, respectively). AUCs of ROC curves were 0.964 for FF and 0.847 for M protein.

CONCLUSIONS

Early change in FF of lumbar BM and serum M protein soon after induction of chemotherapy contributed significantly to prediction of CR/VGPR.

摘要

目的

比较多发性骨髓瘤(MM)患者在完成化疗时的缓解状态,以及在诱导化疗后不久通过全身扩散加权成像(WB-DWI)计算的总扩散体积(tDV)和改良 Dixon Quant(mDixon Quant)的腰椎骨髓(BM)脂肪分数(FF)的变化,并评估 MRI 的预测价值。

方法

50 例有症状骨髓瘤患者(平均年龄 66.9±10.5 岁)在化疗前和化疗后 2 个周期时进行了检查。从 WB-DWI 数据中,使用阳性 BM 受累的阈值获得 tDV。使用 mDixon Quant 序列从腰椎 BM 计算平均 FF。在化疗完成时,将患者分为完全缓解/非常好的部分缓解(VGPR)组(n=15;平均年龄 67.6±10.3 岁)和部分缓解、稳定或进展组(n=35;平均年龄 69.1±8.6 岁)。绘制 ROC 曲线以评估预测实现 CR/VGPR 的性能。

结果

在第二次检查时,CR/VGPR 组的血清 M 蛋白、β2-微球蛋白和 tDV 明显降低,血红蛋白、平均 ADC 和 FF 明显升高,PR/SD/PD 组的血清 M 蛋白明显升高。一般线性模型表明,FF 和 M 蛋白的百分比变化对实现 CR/VGPR 有显著贡献(P=0.02,P=0.04)。FF 和 M 蛋白的 ROC 曲线 AUC 分别为 0.964 和 0.847。

结论

诱导化疗后早期腰椎 BM 的 FF 和血清 M 蛋白的变化对预测 CR/VGPR 有显著贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ad8/7046272/8585f95e8e76/pone.0229607.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ad8/7046272/db11094130de/pone.0229607.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ad8/7046272/8788c698652a/pone.0229607.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ad8/7046272/f648175b7629/pone.0229607.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ad8/7046272/028f437da01c/pone.0229607.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ad8/7046272/8585f95e8e76/pone.0229607.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ad8/7046272/db11094130de/pone.0229607.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ad8/7046272/8788c698652a/pone.0229607.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ad8/7046272/f648175b7629/pone.0229607.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ad8/7046272/028f437da01c/pone.0229607.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ad8/7046272/8585f95e8e76/pone.0229607.g005.jpg

相似文献

1
Assessment of early treatment response on MRI in multiple myeloma: Comparative study of whole-body diffusion-weighted and lumbar spinal MRI.多发性骨髓瘤 MRI 早期治疗反应评估:全身弥散加权和腰椎 MRI 的对比研究。
PLoS One. 2020 Feb 27;15(2):e0229607. doi: 10.1371/journal.pone.0229607. eCollection 2020.
2
Quantitative Analysis of Whole-Body MRI for Accessing the Degree of Diffuse Infiltration Patterns and Identifying High Risk Cases of Newly Diagnosed Multiple Myeloma.全身 MRI 定量分析评估弥漫浸润模式程度和识别新诊断多发性骨髓瘤的高危病例。
J Magn Reson Imaging. 2024 Jun;59(6):2035-2045. doi: 10.1002/jmri.28962. Epub 2023 Sep 7.
3
Prediction of Early Treatment Response in Multiple Myeloma Using MY-RADS Total Burden Score, ADC, and Fat Fraction From Whole-Body MRI: Impact of Anemia on Predictive Performance.使用全身 MRI 的 MY-RADS 总负担评分、ADC 和脂肪分数预测多发性骨髓瘤的早期治疗反应:贫血对预测性能的影响。
AJR Am J Roentgenol. 2022 Feb;218(2):310-319. doi: 10.2214/AJR.21.26534. Epub 2021 Sep 15.
4
Discriminating Depth of Response to Therapy in Multiple Myeloma Using Whole-body Diffusion-weighted MRI with Apparent Diffusion Coefficient: Preliminary Results From a Single-center Study.使用全身扩散加权 MRI 及其表观扩散系数鉴别多发性骨髓瘤的治疗反应深度:一项单中心研究的初步结果。
Acad Radiol. 2018 Jul;25(7):904-914. doi: 10.1016/j.acra.2017.12.008. Epub 2018 Jan 17.
5
Role of whole-body MRI for treatment response assessment in multiple myeloma: comparison between clinical response and imaging response.全身 MRI 在多发性骨髓瘤治疗反应评估中的作用:临床反应与影像反应的比较。
Cancer Imaging. 2020 Jan 30;20(1):14. doi: 10.1186/s40644-020-0293-6.
6
Quantitative bone marrow magnetic resonance imaging through apparent diffusion coefficient and fat fraction in multiple myeloma patients.多发性骨髓瘤患者骨髓磁共振弥散加权成像表观扩散系数和脂肪分数定量分析
Radiol Med. 2021 Mar;126(3):445-452. doi: 10.1007/s11547-020-01258-z. Epub 2020 Aug 18.
7
Comparison of qualitative and quantitative CT and MRI parameters for monitoring of longitudinal spine involvement in patients with multiple myeloma.用于监测多发性骨髓瘤患者脊柱纵向受累情况的定性和定量CT及MRI参数比较
Skeletal Radiol. 2018 Mar;47(3):351-361. doi: 10.1007/s00256-017-2827-y. Epub 2017 Dec 8.
8
Evaluation of Diffuse Bone Marrow Infiltration Pattern in Monoclonal Plasma Cell Diseases by Quantitative Whole-body Magnetic Resonance Imaging.定量全身磁共振成像在单克隆浆细胞疾病弥漫性骨髓浸润模式评估中的应用。
Acad Radiol. 2022 Apr;29(4):490-500. doi: 10.1016/j.acra.2021.06.015. Epub 2021 Aug 4.
9
Apparent diffusion coefficient maps integrated in whole-body MRI examination for the evaluation of tumor response to chemotherapy in patients with multiple myeloma.全身MRI检查中整合的表观扩散系数图用于评估多发性骨髓瘤患者对化疗的肿瘤反应。
Acad Radiol. 2015 Sep;22(9):1163-71. doi: 10.1016/j.acra.2015.05.011. Epub 2015 Jul 14.
10
Treatment Response Assessment in Multiple Myeloma: Histogram Analysis of Total Tumor Apparent Diffusion Coefficient based on Whole-body Diffusion-weighted MR Imaging.基于全身扩散加权磁共振成像的总肿瘤表观扩散系数直方图分析在多发性骨髓瘤治疗反应评估中的应用。
J Magn Reson Imaging. 2024 Sep;60(3):1051-1060. doi: 10.1002/jmri.29155. Epub 2023 Dec 13.

引用本文的文献

1
Early identification of functional high-risk multiple myeloma patients after transplant: the predictive power of fat fraction and Response Assessment Category score in diffusion-weighted whole-body magnetic resonance imaging.移植后功能性高危多发性骨髓瘤患者的早期识别:扩散加权全身磁共振成像中脂肪分数和反应评估类别评分的预测能力
Haematologica. 2025 Sep 1;110(9):2151-2159. doi: 10.3324/haematol.2025.287409. Epub 2025 Apr 3.
2
Diagnostic Innovations: Advances in imaging techniques for diagnosis and follow-up of multiple myeloma.诊断创新:用于多发性骨髓瘤诊断和随访的成像技术进展
J Bone Oncol. 2025 Feb 28;51:100669. doi: 10.1016/j.jbo.2025.100669. eCollection 2025 Apr.
3

本文引用的文献

1
Proton density fat fraction MRI of vertebral bone marrow: Accuracy, repeatability, and reproducibility among readers, field strengths, and imaging platforms.磁共振质子密度脂肪分数成像技术在椎体骨髓中的应用:读者间、场强间和成像平台间的准确性、可重复性和可再现性。
J Magn Reson Imaging. 2019 Dec;50(6):1762-1772. doi: 10.1002/jmri.26748. Epub 2019 Apr 13.
2
Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS).骨髓瘤全身 MRI 采集、解读和报告指南:骨髓瘤反应评估和诊断系统(MY-RADS)。
Radiology. 2019 Apr;291(1):5-13. doi: 10.1148/radiol.2019181949. Epub 2019 Feb 26.
3
Effects of aging on otolith morphology and functions in mice.
衰老对小鼠耳石形态和功能的影响。
Front Neurosci. 2024 Oct 16;18:1466514. doi: 10.3389/fnins.2024.1466514. eCollection 2024.
4
Prediction of mobilized hematopoietic stem cell yield in patients with multiple myeloma: Usefulness of whole-body MRI-derived indices.多发性骨髓瘤患者动员后造血干细胞产量的预测:全身 MRI 衍生指标的应用价值。
PLoS One. 2023 Mar 31;18(3):e0283241. doi: 10.1371/journal.pone.0283241. eCollection 2023.
5
Functional Imaging in the Evaluation of Treatment Response in Multiple Myeloma: The Role of PET-CT and MRI.功能成像在多发性骨髓瘤治疗反应评估中的应用:PET-CT与MRI的作用
J Pers Med. 2022 Nov 10;12(11):1885. doi: 10.3390/jpm12111885.
6
Progress of modern imaging modalities in multiple myeloma.多发性骨髓瘤的现代影像学进展。
Int J Hematol. 2022 Jun;115(6):778-789. doi: 10.1007/s12185-022-03360-6. Epub 2022 May 9.
7
Application of diffusion-weighted whole-body MRI for response monitoring in multiple myeloma after chemotherapy: a systematic review and meta-analysis.扩散加权全身 MRI 在多发性骨髓瘤化疗后疗效监测中的应用:系统评价和荟萃分析。
Eur Radiol. 2022 Apr;32(4):2135-2148. doi: 10.1007/s00330-021-08311-z. Epub 2022 Jan 14.
8
Association of loss of spleen visualization on whole-body diffusion-weighted imaging with prognosis and tumor burden in patients with multiple myeloma.全身扩散加权成像上脾脏不显影与多发性骨髓瘤患者预后和肿瘤负荷的相关性。
Sci Rep. 2021 Dec 14;11(1):23978. doi: 10.1038/s41598-021-03496-1.
9
Radiotherapy Response Assessment of Multiple Myeloma: A Dual-Energy CT Approach With Virtual Non-Calcium Images.多发性骨髓瘤的放疗反应评估:一种采用虚拟去钙图像的双能CT方法
Front Oncol. 2021 Sep 23;11:734819. doi: 10.3389/fonc.2021.734819. eCollection 2021.
10
Imaging of treatment response and minimal residual disease in multiple myeloma: state of the art WB-MRI and PET/CT.多发性骨髓瘤治疗反应和微小残留病的影像学:WB-MRI 和 PET/CT 的现状。
Skeletal Radiol. 2022 Jan;51(1):59-80. doi: 10.1007/s00256-021-03841-5. Epub 2021 Aug 7.
Prediction of Abnormal Bone Density and Osteoporosis From Lumbar Spine MR Using Modified Dixon Quant in 257 Subjects With Quantitative Computed Tomography as Reference.
利用改良 Dixon Quant 对 257 例以定量 CT 为参考的受试者腰椎 MR 进行异常骨密度和骨质疏松预测。
J Magn Reson Imaging. 2019 Feb;49(2):390-399. doi: 10.1002/jmri.26233. Epub 2018 Nov 3.
4
Proton density fat fraction (PDFF) MR imaging for differentiation of acute benign and neoplastic compression fractures of the spine.质子密度脂肪分数(PDFF)磁共振成像在鉴别脊柱急性良性和肿瘤性压缩性骨折中的应用。
Eur Radiol. 2018 Dec;28(12):5001-5009. doi: 10.1007/s00330-018-5513-0. Epub 2018 Jun 1.
5
Whole-body MRI quantitative biomarkers are associated significantly with treatment response in patients with newly diagnosed symptomatic multiple myeloma following bortezomib induction.全身 MRI 定量生物标志物与硼替佐米诱导后新诊断为有症状多发性骨髓瘤患者的治疗反应显著相关。
Eur Radiol. 2017 Dec;27(12):5325-5336. doi: 10.1007/s00330-017-4907-8. Epub 2017 Jun 27.
6
Association between response rates and survival outcomes in patients with newly diagnosed multiple myeloma. A systematic review and meta-regression analysis.
Eur J Haematol. 2017 Jun;98(6):563-568. doi: 10.1111/ejh.12868. Epub 2017 Mar 20.
7
Diffusion-weighted Imaging as a Treatment Response Biomarker for Evaluating Bone Metastases in Prostate Cancer: A Pilot Study.扩散加权成像作为评估前列腺癌骨转移治疗反应生物标志物的初步研究
Radiology. 2017 Apr;283(1):168-177. doi: 10.1148/radiol.2016160646. Epub 2016 Nov 22.
8
Quantitative Diffusion-weighted Imaging of the Bone Marrow: An Adjunct Tool for the Diagnosis of a Diffuse MR Imaging Pattern in Patients with Multiple Myeloma.骨髓定量扩散加权成像:多发性骨髓瘤患者弥漫性 MRI 表现的辅助诊断工具。
Radiology. 2017 Feb;282(2):484-493. doi: 10.1148/radiol.2016160363. Epub 2016 Sep 9.
9
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma.国际骨髓瘤工作组多发性骨髓瘤反应和微小残留病评估的共识标准。
Lancet Oncol. 2016 Aug;17(8):e328-e346. doi: 10.1016/S1470-2045(16)30206-6.
10
Volume of Bone Metastasis Assessed with Whole-Body Diffusion-weighted Imaging Is Associated with Overall Survival in Metastatic Castration-resistant Prostate Cancer.全身扩散加权成像评估的骨转移量与转移性去势抵抗性前列腺癌的总生存相关。
Radiology. 2016 Jul;280(1):151-60. doi: 10.1148/radiol.2015150799. Epub 2016 Jan 25.